Owlet, Inc.

NYSE:OWLT

Medical - Devices

Healthcare
$3.67 +9.76%

+$0.46 today

Market cap
$107.24M
Beta
1.86
P/E (TTM)
-0.4
EPS (TTM)
-$12.67
52W Low $4.19High $16.94

Volume 0.64M

Average 0.24M

OWLT Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

Owlet, Inc.NYSE: OWLT

Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026

Deferred revenue rises 65.3% from a year ago

Deferred revenue stood at $2.41M at the end of Q1 FY2026, up 65.3% from a year earlier and up 4.7% from the prior quarter.

Context

  • Deferred revenue amounted to 2.8% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Deferred revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred revenue keeps rising in the next quarterly balance sheet after a +65.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.41M+4.7% QoQ
Last fiscal yearDec 2025
$2.3M— YoY
Year agoMar 2025
$1.46M+65.3% since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+65.3%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
2.3M USD
Year-over-year change
—
4-year CAGR
+21.3%

Deferred Revenue vs competitors

How OWLT compares with its peers on the latest reported figures

  • OWLT's Mar 2026 deferred revenue of $2.41M is the 4th highest of the 10 companies compared; the peer median is $0.
  • Its year-over-year change of +65.3% is the highest of 4, against a peer median of +8.9%.
  • Deferred revenue amounts to 2.8% of total assets for OWLT, versus a peer median of 0.0%.
OWLT Competitors Peer median
Deferred Revenue for OWLT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
RPIDRapid Micro Biosystems, Inc.Mar 2026$6.63M +8.9%+0.2%10.6%
MXCTMaxCyte, Inc.Mar 2026$3.27M -21.1%—1.7%
LNSRLENSAR, Inc.Mar 2026$3.01M +51.2%+58.8%4.5%
OWLTOwlet, Inc.Mar 2026$2.41M +65.3%—2.8%
ANIKAnika Therapeutics, Inc.Mar 2026$229K ——0.1%
AVRAnteris Technologies Global Corp.Mar 2026$0 ——0.0%
LUCDLucid Diagnostics Inc.Mar 2026$0 ——0.0%
CRBPCorbus Pharmaceuticals Holdings, Inc.Mar 2026$0 ——0.0%
CRDFCardiff Oncology, Inc.Mar 2026$0 ——0.0%
ELTXElicio Therapeutics, Inc.Mar 2026$0 ——0.0%
Peer median (excluding OWLT) $0+8.9%+29.5%0.0%

Competitors are the stored peer set for OWLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents95.05M11.23M16.56M20.25M35.5M
Short-term Investments00000
Net Receivables10.47M15.96M13.97M12.14M22.9M
Inventory17.98M18.52M6.49M10.52M15.3M
Other Current Assets001386K8.2M
Total Current Assets135.82M51.26M39.94M46.11M81.9M
Property, Plant & Equipment (Net)1.87M3.37M1.31M240K400K
Goodwill00000
Intangible Assets1.7M2.28M2.21M975K1.4M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets666K1.2M655K2.19M1.9M
Total Non-current Assets4.23M6.84M4.18M3.4M3.7M
Total Assets140.05M58.1M44.12M49.52M85.6M
Account Payables27.77M30.43M13.68M11.28M12M
Short-term Debt8.53M15.04M15.19M7.37M10.57M
Tax Payables00000
Deferred Revenue1.06M0002.3M
Other Current Liabilities08.62M4.09M2.31M(94K)
Total Current Liabilities69.09M66.6M45.09M36.43M44.2M
Long-term Debt7.99M004.33M2.46M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities7.77M975K28.69M29.82M3.47M
Total Non-current Liabilities15.77M2.14M28.71M34.23M5.93M
Total Liabilities84.86M68.74M73.8M70.66M50.2M
Common Stock11K1K1K2K3K
Retained Earnings(143.42M)(222.76M)(255.66M)(268.2M)(307.87M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity55.19M(10.64M)(29.68M)(21.15M)35.4M
Total Debt16.53M18.31M16.39M11.87M13.03M
Net Debt(78.53M)7.07M(172K)(8.38M)(22.47M)

Owlet, Inc.

NYSE:OWLT

Intrinsic Alpha fair value

Locked

Current Price

$3.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.